<DOC>
	<DOCNO>NCT01480336</DOCNO>
	<brief_summary>The purpose study learn combination therapy amiodarone ranolazine ( approve drug chest pain ) help prevent arrhythmia .</brief_summary>
	<brief_title>The Adjunctive Ventricular Arrhythmia Suppression Trial ( AVAST ) Pilot</brief_title>
	<detailed_description />
	<mesh_term>Ranolazine</mesh_term>
	<mesh_term>Amiodarone</mesh_term>
	<criteria>Patients ICD stable dose amiodarone past 60 day Patients life expectancy le 6 month Patients moderate severe hepatic impairment ( ChildPugh Classes B C ) require hemodialysis . Pregnancy lactation . Treatment potent CYP3A inhibitor , include ketoconazole , itraconazole , clarithromycin , nefazodone , nelfinavir , indinavir , saquinavir Treatment CYP3A inducer , include rifampin , rifabutin , rifapentine , phenobarbital , phenytoin , carbamazepine , St. John 's wort .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Arrhythmia</keyword>
</DOC>